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Abstract
Background: A decoction composed of Adenanthera pavonina L. and Thespesia populnea L. is currently being used
in the treatment of cancer patients.
Methods: Lactate Dehydrogenase (LDH) release, (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide)
MTT, and Sulforhodamine B (SRB) assays were carried out to study cytotoxicity and anti-proliferative activity against
the HEp-2 cells, 24 h post-treatment with the decoction.
Results: The mean (± SD) values of EC50 were 195.50 (±40.68), 120.02 (±29.82) and 77.06 (±8.80) μg/ml for LDH,
MTT, and SRB assays respectively. These results strongly correlate the morphological changes observed in cells
treated with the decoction. Induction of apoptosis was visualized by fluorescence microscopy stained with
ethidium bromide/acridine orange dye mix. In addition, brine shrimp lethality assay showed an EC50 value at a
higher concentration (1.96 mg/mL).
Conclusions: These results suggest that the decoction prepared with Adenanthera pavonina L. and Thespesia
populnea L. exhibits anti-proliferative activity and induces apoptosis on the HEp-2 cancer cells but no toxicity
against Artemia salina.
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Background
Cancer has been an important issue in medicine as it is
one of the major causes of death in both the developed
and developing countries and is now recognised only to
be secondary to myocardial infarction [1]. The discovery
of novel anticancer therapeutics from natural sources,
mainly from plants of medicinal value remains pivotal.
Firstly, the broad spectrum of inherent toxicities associ-
ated with contemporary anticancer agents and secondly
the acquired resistance to currently available drugs war-
rants cancer researchers to explore further, the ability of
natural products to engage as potential anticancer agents
[2]. Traditional medical practitioners have been using
crude drug extracts and biologically active compounds,
isolated from plant species for a number of years. Some
of the prescriptions used in Sri Lanka have been studied
for anticancer activity in vitro using cancer cell lines [3, 4].
In our study, we are evaluating the anticancer properties of
a complete decoction currently used to cure chronic cancer
patients. The decoction used in the present study contains
Adenanthera pavonina L. and Thespesia populnea L. Both
of these plants have numerous medicinal applications.
Some of them include the anti-diabetic, anti-hyperlipidemic
activity [5], antinociceptive, anti-inflammatory effects [6],
antibacterial activity [7] and pharmacological effects related
to Alzheimer’s disease [8] by Thespesia populnea L. Simi-
larly, Adenanthera pavonina L. contains anti-inflammatory
[9, 10], anti-bacterial [11], anti-hyperglycemic, lipid redu-
cing potential [12] antioxidant and cytotoxicity properties
[13]. A decoction prepared in combination with these two
plants, Adenanthera pavonina L. and Thespesia populnea
L. has been used for years to cure cancer patients by indi-
genous practitioners. A previous study carried out in our la-
boratory has shown that the same decoction possesses
strong antioxidant activity in vitro [14]. Hence, the present
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study was carried out to evaluate the scientific validity of
the decoction on anticancer properties.
Methods
Materials and equipment
Chemicals were purchased from Sigma Chemicals Co.
(P.O. Box 14508, St. Louis, MO 63178 USA) and Fluka
(Flukachemie GmbH, CH-9471 Buchs). Lactate De-
hydrogenase (LDH) enzyme assay kits were purchased
from Roche (Roche Diagnostics GmbH, Germany) and
Randox (Randox Laboratories Ltd., Crumlin Co. Antrim,
UK). All chemicals used were of analytical grade. The
decoction was freeze dried using LFT 600EC freeze
dryer equipped with an external pump (Hitachi, Japan).
SHIMADZU UV 1601 UV- Visible spectrophotometer
(Shimadzu Corporation, Kyoto, Japan) was used to read
the absorbance. Cells were observed using Olympus
(1X70-S1F2) inverted fluorescence microscope (Olympus
Optical Co. Ltd. Japan), and Nikon D700 (105 mm macro
lens, film speed 1000 asa, Japan) was used to capture the
photographs. Deionised water used in all experiments
was obtained from LABCONCO (waterproplus) UV
ultra-filtered water system (LABCONCO Corporation,
Kansas city, Missouri 64132–2696).
Plant materials and preparation of the decoction
The phytochemical composition of this decoction was
previously determined by our laboratory [14]. The mean ±
SD of the total phenols and flavonoids were determined
to be 34.14 ± 3.54 w/w % gallic acid equivalents and
42.40 ± 0.39 w/w % EGCG equivalents respectively. The
presence of these phytochemicals may contribute to the
apoptotic effects observed. To prepare the decoction,
the barks of Thespesia populnea L. (Indian tulip tree/
Pacific rosewood/Bebaru/Gansuriya) were collected from
live plants in Deniyaya (Matara District) and the barks of
Adenanthera pavonina L. (Red bead tree/Coral tree/Red
Sandalwood tree /Madatiya) were obtained from Kotte,
Colombo district, Sri Lanka [14]. All plant materials were
identified and confirmed by the Department of Botany,
Bandaranayake Memorial Ayurveda Research Institute,
Nawinna, Colombo, Sri Lanka and voucher specimens are
available at the same premises. The barks of Thespesia
populnea L. (30 g) and Adenanthera pavonina L. (30 g)
were used in equal proportion to prepare the decoction.
The recipe for decoction was provided by Dr. Nimal
Jayathilake, Consultant Physician, Bandaranayake Ayur-
vedic Research Institute, Nawinna, Maharagama. All the
plant ingredients were made into smaller pieces and a fine
powder was obtained using a clean kitchen blender. The
contents were then boiled with 1.6 L of water in a clay pot
with a lid. Boiling was allowed to continue until the vol-
ume decreased to 200 ml (1/8th of the original volume).
The aqueous extracts were subsequently decanted and
filtered through a piece of clean cheese cloth (Vijay
Auction, Colombo, Sri Lanka). The extract was then
centrifuged at 1000 rpm for 5 min. The supernatant
was retained and the pellet was solubilised with a minimum
quantity of deionised water, sonicated and centrifuged at
2500 rpm for 8 min. Both supernatants were pooled
and then freeze dried. The freeze dried samples were
stored at −20 °C in sterile tubes until further use. Three
individually prepared decoctions were made according
to the above procedure.
Cell line
HEp-2 cell line originally obtained from Medical Research
Institute, Sri Lanka, which was preserved and maintained
in the Department of Biochemistry and Molecular Biology,
was used for all cytotoxic experiments.
Cell culture and preparation of the cells for cytotoxicity
Cells were cultured in Eagle’s Minimum Essential Medium
(EMEM) supplemented with 10 % fetal bovine serum
(FBS), MEM non-essential (1 %), L-glutamine (3 %),
50 IU/ml penicillin and 50 μg/ml streptomycin. The pH of
the growth media were adjusted to physiological pH (7.4)
using 7.7 % sodium bicarbonate. Cells were maintained at
37 °C in a 5 % carbon dioxide (CO2). The cells were
seeded in a 24-well plate (2 × 105) and cultured overnight.
Confluent monolayer was treated with different concen-
trations of the decoction at 37 °C for 24 h in humidified
CO2 incubator. In all experiments, a negative control
without the decoction and a positive control with camp-
tothecin (5 mM) were used.
MTT assay
MTT (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) assay is a semi-automated colorimetric
assay based on the principle that the mitochondria of live
cells reduce the tetrazolium salt, MTT to blue formazan
compounds [15]. The cells were cultured overnight on 24-
well plates as described above and treated with different
concentrations (50–500 μg/ml) of the decoction for 24 h
at 37 °C in a humidified CO2 incubator. The negative
control without the plant extract was used and the final
volume of each well was adjusted to 1 ml with growth
media. After 24 h, the supernatant was subsequently re-
placed with regular media (1 ml) followed by the addition
of MTT (5 mg/ml in PBS). The cells were incubated at
37 °C for 4 h and the media was carefully removed. The
formazan crystals were then dissolved in acidified iso-
propanol (0.05 M HCl in IPA) by mixing well with pip-
ette tip. The absorbance of the resulting solution was
measured at 570 nm. Acidified IPA was used to zero
the spectrophotometer. The percentage viability was
calculated as given below:
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% Cell Viability
¼ Absorbance of treated cells Absorbance of untreated cellsð Þ  100
The net absorbance from the wells of untreated cells
was taken as 100 % viable. The experiment was carried
out in triplicates.
Lactate dehydrogenase (LDH) activity
The changes in the membrane permeability can be detected
by the leakage of enzymes such as lactate dehydrogenase.
The cells were treated with the decoction at different con-
centrations (50 – 500 μg/ml) for 24 h. The culture superna-
tants (200 μl) and cell lysates (200 μl) were tested for the
presence of LDH enzyme, using the LDH detection kit.
% Cytotoxicity
¼ 1−LDH activity in the supernatant  Total LDH activityð Þ  100
The experiment was performed in triplicates.
Sulforhodamine B assay
The Sulforhodamine B (SRB) assay, first described by
Skehan and colleagues (1990) is based on the ability of
the SRB dye to bind electrostatically to the basic amino
acid residues [16]. The monolayer of cells was treated at
different concentrations (40–160 μg/ml) of the decoction
and cultured overnight in a humidified CO2 incubator.
The medium was then removed completely. The adherent
cells were treated with trichloroacetic acid (10 %; 500 μl)
to fix the cellular protein and the plate was incubated at
4 °C for at least 1 h prior to the SRB assay. The plate was
then washed with five washing cycles using deionised
water and dried completely. A volume of 500 μl of SRB
(0.4 %; in 1 % acetic acid) was added to each well and
allowed to stain for 30 min. The excess stain was removed
and the plate was subjected to five washing cycles again to
remove unbound dye using 1 % acetic acid (vol/vol). After
air-drying, the protein bound dye was solubilised with Tris
base (10 mM; 500 μl) and the plates were shaken for
at least 30 min. The absorbance was then recorded at
564 nm using Tris base as blank. The percentage viability
was calculated as given below:
% Cell Viability
¼ Absorbance of treated cells Absorbance of untreated cellsð Þ  100
The experiment was carried out in triplicates.
Morphological determination
Cells (2 × 105 cells per well), were seeded in 24-well
plates and exposed to the decoction at two different
concentrations (50 and 100 μg/ml) for 24 h as described
earlier. The morphological changes of cells were observed
using Olympus (1X70-S1F2) inverted fluorescence micro-
scope at 100X magnification and photographed using
Nikon D700 camera. A negative control (untreated cells)
and a positive control (Camptothecin: 5 mM) were also
analysed for comparison.
Ethidium Bromide/Acridine Orange Staining (EB/AO staining)
Differential uptake of dyes that bind to DNA is tech-
nique that is used to determine the mode of cell death,
especially the difference between apoptosis and necrosis
[17]. Most of the live cells are permeable to acridine or-
ange (AO) and hence the nuclei of AO-stained cells ap-
pear green. In contrary, ethidium bromide (EB), which
stains red, enters the cell only when there is a loss in the
cell membrane integrity. Thus live cells exhibit green
nuclei, early apoptotic cells bright green nuclei with
fragmented chromatin and late apoptotic cells have con-
densed and fragmented orange chromatin. However, the
necrotic cells will possess a normal orange/red nucleus
with no aberrant changes [18].
Induction of apoptosis by the decoction was investi-
gated with AO/EB dye staining as described by Ribble
et al. [18]. The cells (2 × 105) were treated with two
different concentrations (50 and 150 μg/ml) of the de-
coction and cultured overnight in a humidified CO2
incubator at 37 °C. The media was transferred to
15 ml tubes. The rest of the adherent cells were de-
tached with Trypsin-EDTA (1 ml) and incubated at
37 °C for 2 min. The media and the detached cells
from the same sample were pooled together and centri-
fuged at 1,000 rpm for 5 min. Cell pellets were then re-
suspended in 25 μl cold PBS and 2 μl EB/AO dye mix
(EB/AO dye mix contained 100 μg/ml of each dye).
Stained cell suspensions (10 μl) were visualized using
an Olympus (1X70-S1F2) inverted fluorescence micro-
scope at 100X magnification and photographed using
Nikon D700 camera.
Brine shrimp lethality assay
Brine shrimp lethality bioassay was carried out to investi-
gate the general cytotoxicity of the decoction [19]. Brine
shrimps (Artemia salina) were hatched using brine shrimp
eggs in a petri dish (diameter – 85 mm) filled with 12 ml of
filter-sterilized sea water (pH 8.5) for a period of 24 h under
aeration. Ten nauplii were drawn through a pipette and
placed in 24-well plates (final volume 2 ml) at different con-
centrations of the decoction. The plate was maintained at
room temperature for 24 h under aeration and the surviv-
ing larvae were counted. Experiments were conducted
along with a negative control. The percentage lethality was
calculated from the mean survival larvae of extracts treated
with the decoction and control. The experiment was
carried out in triplicates.
% Lethality
¼ Mean survival larvaeMean larvae in untreated controlð Þ  100
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Calculations and statistics
A minimum of three independent experiments were car-
ried out unless otherwise specified. Linear regression
analysis were carried out using Microsoft Excel. Calibra-
tion curves of the standards were considered as linear if
R2 > 0.99. Linear segment of the sigmoid curves of the
dose response curves between percentage cell viability and
log concentration were used to determine the EC50 values.
Results
MTT assay
The cell viability was determined by MTT reduction
assay after 24 h treatment with decoction as described
earlier. A dose–response curve for the percentage of
viable cells was plotted against concentrations of the
extract. Maximum growth inhibition was shown at
concentrations over 300 μg/ml, however, the cell viability
remained unchanged and the decoction was not effective
in cytotoxicity at concentrations <80 μg/ml. The EC50
value obtained was 120.02 ± 29.82 μg/ml (Fig. 1a).
LDH activity
LDH release into the medium and subsequent reduction
in NADH concentration was used as an index of the in-
tegrity of cell membranes and on this basis, percentage
LDH released was calculated as described previously. A
dose dependent increase of LDH release was observed
with the decoction with an EC50 value of 195.50 ±
40.68 μg/ml (Fig. 1b). A maximum inhibition of 80 %
was observed at concentrations over 350 μg/ml of the
decoction. The LDH release for negative and camptothe-
cin (positive control) were 21 and 41 % respectively.
Sulforhodamine B (SRB) assay
The effect of the decoction on HEp-2 cell survival was
determined by the SRB assay as previously described. A
dose-dependent inhibition was observed with an inhib-
ition of 78.54 % at concentration of 160 μg/ml. The
EC50 value for the decoction was observed at 77.06 ±
8.80 μg/ml (Fig. 1c).
Cell morphology studies and Ethidium Bromide/Acridine
Orange Staining (EB/AO staining)
The cytotoxic effects of the decoction on HEp-2 cells
were analyzed using an inverted fluorescence microscope
as depicted in the Fig. 2, top panel. The figures show the
potential of the decoction in inducing apoptosis in the
HEp-2 cells by demonstrating the morphological changes
characteristic to apoptosis such as membrane blebbing,
cell shrinkage, nuclear and cytoplasmic condensation and
formation of apoptotic bodies as compared to the negative
control. Apoptotic and necrotic cells were further investi-
gated using fluorescence microscopy and double staining
with ethidium bromide and acridine orange (Fig. 2-bottom
panel). Live cells displayed a uniformly green fluorescence
which had regular, round-shaped nuclei in the absence
of decoction (Fig. 2e). The early apoptotic cells were
observed at a concentration of 50 μg/ml, which the
cells were still green in color with bright green dots in
their nuclei corresponding to nuclear fragmentation
(Fig. 2f). The late apoptotic cells were visible at concentra-
tion of 150 μg/ml of the decoction and in positive control,
camptothecin (5 mM) which had stained orange attributed
to incorporation of both ethidium bromide and acridine
orange (Fig. 2g & h).
Brine shrimp lethality assay
Brine shrimp lethality is the simplest bioassay useful for
screening large number of extracts in the drug discovery
process. Preliminary experiments carried out at a concen-
tration range of 50 – 800 μg/ml did not show any toxic ef-
fect on brine shrimp assay. However, the number of live
brine shrimps decreased with a concentration >1.5 mg/ml
with an EC50 of 1.96 ± 44.84 mg/ml (Fig. 3).
Discussion
Complementary and alternative medicine (CAM) is very
popular in the contemporary world and is widely adopted
around the globe [20]. A decoction, containing barks of
Thespesia populnea and Adenanthera pavonina is used in
the treatment of cancer by traditional physicians in Sri
Lanka. Lyophilized samples of this extract were studied
for its phenolic and antioxidant activity and the findings
were previously published [14]. The results of this initial
study clearly demonstrated that the potent antioxidant
activity of the decoction is justified by its high phenolic
constituents and flavonoids. Therefore, we initiated to
evaluate the cytotoxic properties using a range of assays
to provide evidence of potent anticancer abilities of the
decoction.
In this study, the anti-proliferation and induction of
apoptosis by the decoction were studied using MTT,
LDH and SRB assays with HEp-2 cell line. It was found
that the decoction significantly inhibited the prolifera-
tion of HEp-2 cells after incubation of the cells for a
period of 24 h and the results showed a concentration-
dependent decrease in the percentage cell viability of the
HEp-2 cell line.
The observation of apoptotic cells at higher concentra-
tions suggest that the effect of the decoction is cytocidal
at least at higher concentrations. We also feel that the
cytocidal or cytostatic phenotype mostly depends on the
concentration used and the incubation time. When we use
a concentration close to the EC50 of the drug (150 μg/ml),
the apoptotic signal appears to be stronger that when the
concentration of the decoction was used three times lesser
than the EC50 (50 μg/ml), suggesting that the effect of the
decoction was dose-dependent. The two concentrations of
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the decoction, we have included in the manuscript,
provides two clear phenotypes of early and late apoptosis
incurred by the decoction.
Previous studies conducted by Boonsri et al. (2008)
evaluated the cytotoxic properties of Thespesia populnea
[21]. In their study, the heartwood and wood were
Fig. 1 Cytotoxicity of HEp-2 cells induced by the decoction as determined by different cytotoxicity assays. a MTT assay was used to determine
the percentage cell viability as described in the text. b The percentage LDH released after 24 h of treatment with the decoction. Hep-2 cells were
treated with different concentrations of the decoction for a period of 24 h. Percentage LDH released was used to construct a dose response curve
and the linear segment of this curve was used to determine EC50 value. ‘Neg’ and ‘Pos’ indicates untreated and 5.0 mM camptothecin-treated
samples respectively. c Cytotoxicity of HEp-2 cells induced by the decoction as determined by SRB assay. Dose response curve for cell viability for
decoction prepared with Adenanthera pavonina L. and Thespesia populnea L was used to determine the EC50 value using the linear segment of
the curve. The results are presented as mean ± SD of at least three independent experiments
Lindamulage and Soysa BMC Complementary and Alternative Medicine  (2016) 16:70 Page 5 of 8
separately extracted from T. populnea in dichloromethane
and these extracts were shown to induce a potent cyto-
toxic ability against different cancer cell lines, including
MCF-7, HeLa, HT-29, and KB cells. In addition, Johnson
et al. (1999) extracted four quinones, namely mansonone-
D, mansonone-H, thespone and thespesone from the
heartwood of T. Populnea and evaluated their cytotoxicity
in MCF-7 breast cancer cells [22]. Mansonone-D and
Thespone showed enhanced cytotoxic effects than the
other two quinones, mainly owing to generation of
superoxide anions, which the authors speculate to be
responsible for the cell killing effect. Masuda et al.
(2002) evaluated the cytotoxic activity of leaf extracts
in sea shore plants in the subtropical regions of Japan
via flow cytometry using ethidium bromide and annexin
V-FITC as fluorescent probes. One of these plants was T.
Populnea and the leaf extracts exhibited potent cytotoxic
effect against human leukemic cell line, K562 [23]. It is in-
teresting to observe the presence of several natural occur-
ring cytotoxic compounds in T. populnea and one of
compounds, most elaborately studied is Gossypol [24].
Gossypol is present usually in members of the Malvaceae
family, including cotton plant (Gossypium species) and in
Thespesia populnea. Gossypol has been shown to exhibit
potent anti-proliferation ability against a range of human
cancer cells, including ovarian, endometrial, colon, cervical,
lung, colon, leukemia and melanoma [14, 15, 17–22, 25-33,
36]. More interestingly, gossypol also showed cytotoxic
property against cell lines resistant to vinblastine, adriamy-
cin and cisplatin [29]. Further studies involving clinical tri-
als showed minimal adverse effects, however the response
rates of the receiving patients were low [34–36]. Hence
additional studies need to be performed to explore either
Fig. 3 Effect of different concentrations of the decoction on the
viability of the brine shrimps. The linear segment of the curve was
used to calculate the EC50 values by linear regression analysis. The
results are presented as mean ± SD of three independent experiments
Fig. 2 Images of HEp-2 cells on treatment with/without the decoction by light and fluorescence microscopy. (Top panel) Light micrographs
(Phase contrast) of cultured HEp-2 cells after 24 h of incubation. a Untreated control cells b Cells incubated with camptothecin (5 mM; 25 μl) as
positive control. c and d cells incubated with 50 and 100 μg/ml of the decoction respectively. (Bottom panel) Images of cells after treating with
acridine orange-ethidium bromide staining. Untreated cells show a uniform green fluorescence e; cells treated with 50 μg/ml decoction appeared
green with bright green nuclei indicating nuclear fragmentation and early apoptotic cells f; with 150 μg/ml of decoction g and camptothecin
(5 mM; 25 μl) as the positive control h show late apoptotic cells by the orange red appearance due to the incorporation of both ethidium bromide
and acridine orange. Yellow and red arrows indicate early and late apoptotic cells respectively. (Magnification 100X)
Table 1 Summary of the cytotoxic activities of the decoction
composed of Thespesia populnea L. and Adenanthera pavonina L.
EC50 (n = 3)
Brine Shrimp LDH MTT SRB
(mg/ml) (μg/ml) (μg/ml) (μg/ml)
Decoction 1.96 ± 44.84 195.50 ± 40.68 120.02 ± 29.82 77.06 ± 8.80
Percentage growth inhibition at 5.0 mM
Camptothecin ND 41.39 ± 4.92 50.50 ± 6.02 45.06 ± 7.05
ND Not determined
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a new extract or a synergistic combination with an add-
itional compound.
Studies were performed with the barks of A. pavonina
in respect to their anti-inflammatory abilities [37]. How-
ever, recent reports have also demonstrated the cytotoxic
potential of the ethanolic seed extracts of A. pavonina.
Ferreira et al. (2011) reported that, after 72 h of treatment
with ethanolic seed extracts of A. pavonina (50 μg/mL),
there was a 30.8 ± 5.2, 23.7 ± 3.2, 4.5 ± 2.4, and 1.2 ±
13.2 % proliferation inhibition for HCT-8, SF-295, MDA
MB-435 and HL-60 cells respectively [38]. However, stud-
ies on cytotoxic potential of the bark of this plant have
been explored only to a minimal extent. Hence, this is the
first instance where the cytotoxic ability of a decoction
composed of barks of Thespesia populnea and Ade-
nanthera pavonina is described. The decoction displayed
cytotoxic effects against the HEp-2 cell line, however,
the toxic doses for brine shrimp larvae are in the range
10–100 times higher in comparison to cell culture
methods. The brine shrimp lethality assay has been widely
used to screen toxicity and the level of toxicity of pesti-
cides, dental materials, crude plant extracts and fractions,
secondary metabolites and nanoparticles [39, 40]. Meyer
(1982) has reported that extracts obtained from natural
products which have LC50 ≤ 1.0 mg/mL are known to pos-
sess toxic effects [19]. The present study shows an EC50
value of 1.96 mg/mL for brine shrimp assay, whereas for
studies on anti-proliferation of cancer cells, the value
ranges from 77 to 195 μg/ml proving that no such toxic
effects exists on Artemia salina.. However the toxicity
studies against a normal mammalian cell line is still
remain to be established.
Conclusions
The results obtained from the present study shows that
the decoction containing Adenanthera pavonina L. and
Thespesia populnea L. possesses potent anti-proliferative
and cytotoxic activities (Table 1). The claim by traditional
healers that the decoction containing Adenanthera pavo-
nina L. and Thespesia populnea L. is partially validated in
the present study by identifying its aqueous extract to con-
tain apoptotic activity. If some of the compounds are
structurally identified and characterized, they may be can-
didates for further anticancer drug development.
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